Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential.
Cooper RA. et al, (2024), Leukemia
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.
Watson RA. et al, (2024), J Immunother Cancer, 12
Impact of the transition to digital pathology in a clinical setting on histopathologists in training: experiences and perceived challenges within a UK training region.
Browning L. et al, (2023), J Clin Pathol, 76, 712 - 718
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.
Taylor CA. et al, (2022), Nat Med, 28, 2592 - 2600
Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity.
Gilchrist JJ. et al, (2022), Nat Commun, 13
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity.
Watson RA. et al, (2021), Sci Immunol, 6
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Ye W. et al, (2021), Br J Cancer, 124, 1661 - 1669
Counting Intraepithelial Lymphocytes: A Comparison Between Routine Staining and CD3 Immunohistochemistry.
Cooper R. et al, (2020), Int J Surg Pathol, 28, 367 - 370
A novel stratification framework for predicting outcome in patients with prostate cancer.
Luca B-A. et al, (2020), Br J Cancer, 122, 1467 - 1476
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma.
Fairfax BP. et al, (2020), Nat Med, 26, 193 - 199
DESNT: A Poor Prognosis Category of Human Prostate Cancer.
Luca B-A. et al, (2018), Eur Urol Focus, 4, 842 - 850